Navigation Links
Multiple Allergies and Medicines Leave Patients With Mixed Messages
Date:11/8/2013

MCLEAN, Va., Nov. 8, 2013 /PRNewswire-USNewswire/ -- Nasal allergies serious enough for treatment with corticosteroids require diagnosis and ongoing management by board-certified allergists, according to a recent social media survey of patients and caregivers. Conducted by leading nonprofit patient education group Allergy & Asthma Network Mothers of Asthmatics (AANMA), the survey is being presented in scientific sessions at the 70th Annual Scientific Meeting of the American College of Allergy, Asthma and Immunology (ACAAI).

People who use or administer corticosteroid nasal sprays to children generally reported having multiple medical conditions and symptoms for which they used multiple prescription and other medications, says Nancy Sander, AANMA founder and survey author. Those whose care came from allergists reported greatest satisfaction with the treatment plan. Nearly all (91.4%) said best outcomes came from seeing a physician; 76.9% choose an allergist.

"Our survey responders were all previously diagnosed and relatively well versed in how to correctly use nasal corticosteroids, but the results show a lot of room for improvement in patient education," says Stanley Fineman, MD, MBA, FACAAI, lead medical investigator for the survey and past president of ACAAI. "It is important to know why you are using an intranasal corticosteroid, when to start and stop using it, how to know if it is meeting treatment expectations, how often to have someone examine the inside of your nose and the reasons why, and how often to have your eyes examined."

"It's not intuitive information or something you know just by reading a label" adds Sander. "You can't do a nasal self-examination at home to see if your nasal tissue is boggy and allergic or sickly like a cold, or if it's infected, deviated or full of sores."

"This study also reinforces that we could all be doing a better job educating patients about medications," Fineman continues. "I'm pleased that ACAAI accepted this study for presentation at our annual scientific meeting. It is time for more education and collaboration among patient advocacy groups such as AANMA and professional organizations such as ACAAI to ensure best outcomes for patients."

Must-Know Corticosteroid Nasal Spray Info:

  • Should be started before allergy season begins.
  • Should not be used to treat cold symptoms.
  • Does not give immediate relief.
  • More isn't better.
  • If you have allergies, see a board-certified allergist and obtain a personalized prevention strategy to outsmart and overcome symptoms with minimal need for medication.
  • Read package instructions. Aim the nasal spray away from nasal septum to help avoid unwanted side effects.
  • If you can't tolerate water-based sprays, dry aerosol sprays may be an option.
  • If you use other corticosteroids, such as eye drops, skin cream, asthma/COPD inhalers, nebulizer solutions or oral medications, talk to your doctor before using a nasal spray corticosteroid, to avoid risk of causing a systemic effect.
  • See your ophthalmologist annually if you are at risk for cataracts.

Results of AANMA's Corticosteroid Nasal Spray Survey are the subject of a poster presentation this weekend at the 2013 Annual Scientific Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Baltimore. The poster and accompanying abstract were prepared by Dr. Fineman and Emory University School of Medicine allergy fellows Anthony Nguyen, DO, and Marissa Shams, MD, along with AANMA's Nancy Sander and Laurie Ross.

ABOUT AANMA

Allergy & Asthma Network Mothers of Asthmatics (AANMA) is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. AANMA specializes in sharing family-friendly, medically accurate information through its award-winning publications Allergy & Asthma Today magazine and The MA Report newsletter, its web site at www.aanma.org and numerous community outreach programs. Follow AANMA on Facebook at facebook.com/AANMA and on Twitter at twitter.com/AANMA.

Find a board certified allergist (www.AllergyandAsthmaRelief.org) for accurate testing, diagnosis and a personalized treatment plan.

Contact: Laurie Ross
Allergy & Asthma Network
Mothers of Asthmatics
703-795-4142
lross@aanma.org


'/>"/>
SOURCE Allergy & Asthma Network Mothers of Asthmatics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes
2. Medac Pharma, Inc. Announces Multiple Poster Presentations During the 2013 ACR/ARHP Annual Meeting
3. EMD Serono Exclusive Supporter of Newly Launched Multiple Sclerosis Resource Centre
4. Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other Oral Multiple Sclerosis Therapies
5. Teva Pharmaceuticals Donates to the National Multiple Sclerosis Society in recognition of Jack Osbourne as He Competes on "Dancing with the Stars"
6. Multiple International Breast Cancer Guidelines Confirm Use of Agendia Tests for Prognostic, Predictive Information in Cancer Treatment Decisions
7. Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idecs Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
8. Genalyte And Barbara Davis Diabetes Center Collaborate To Advance Multiplexed Antigen Panel For Early Diagnosis Of Type 1 Diabetes
9. Emdeon Continues Focus on Patient-Centered Healthcare Solutions; Renews Chain Drug Consortium Contract for Multiple Pharmacy Solutions
10. Physicians Practice Wins Multiple Awards for Digital and Print Excellence
11. Millstone Increases Inspection Capabilities in Multiple Locations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... compound DMT210, in a Phase 2 acne rosacea ... to downregulate the proinflammatory cytokines in the skin ... acne rosacea. This clinical trial, ...
(Date:1/18/2017)... 18, 2017 The report " Automated Breast Ultrasound System ... Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook ... Argentina , Germany , UK, France ... Russia , China , Japan , ... , Saudi Arabia , UAE, South Africa ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... 18, 2017 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that Mr. Michael Merges, Director of Strategic Growth, Catalent ... held at the Mayflower Hotel, Washington DC, on Jan. 24 – 26, 2017. ...
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s ... and the perfect time for a reset. The U.S. Apple Association agrees and recommends ... many of the factors that contribute to heart disease. , The U.S. Apple Association ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and ... or those who desire a more intimate review and analysis of its highlights, a ... to Bedside—is being offered by Imedex on February 4, 2017 in Chicago. Chaired by ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic ... National Association of Music Merchants (NAMM) winter trade show, Booth #2876, at the ... ER•4® has long been the gold standard for high-definition, in-ear earphones. This classic ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is ... Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, ... an exciting addition to our provider network, and the addition will benefit our ...
Breaking Medicine News(10 mins):